News for Healthier Living

Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy

A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Center (UMMC) with her own genetically engineered stem cells in an effort to prevent life-threatening complications and achieve a long-term cure.

April 29, 2026


April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026

April 17 2026